Annual Total Expenses
$36.89 B
+$1.38 B+3.87%
31 December 2023
Summary:
Novartis AG annual total expenses is currently $36.89 billion, with the most recent change of +$1.38 billion (+3.87%) on 31 December 2023. During the last 3 years, it has fallen by -$2.85 billion (-7.18%). NVS annual total expenses is now -24.08% below its all-time high of $48.59 billion, reached on 31 December 2011.NVS Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$9.54 B
+$687.00 M+7.76%
30 September 2024
Summary:
Novartis AG quarterly total expenses is currently $9.54 billion, with the most recent change of +$687.00 million (+7.76%) on 30 September 2024. Over the past year, it has dropped by -$785.00 million (-7.60%). NVS quarterly total expenses is now -31.32% below its all-time high of $13.90 billion, reached on 31 December 2011.NVS Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVS Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.9% | -7.6% |
| 3 y3 years | -7.2% | -5.8% |
| 5 y5 years | -2.1% | -5.7% |
NVS Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -7.2% | +8.8% | -12.1% | +158.7% |
| 5 y | 5 years | -7.2% | +8.8% | -12.4% | +158.7% |
| alltime | all time | -24.1% | +155.5% | -31.3% | +191.2% |
Novartis AG Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $9.54 B(+7.8%) |
| June 2024 | - | $8.86 B(+1.3%) |
| Mar 2024 | - | $8.75 B(-4.9%) |
| Dec 2023 | $36.89 B(+3.9%) | $9.19 B(-11.0%) |
| Sept 2023 | - | $10.33 B(+15.6%) |
| June 2023 | - | $8.94 B(+6.0%) |
| Mar 2023 | - | $8.43 B(-8.5%) |
| Dec 2022 | $35.52 B(+4.7%) | $9.21 B(+2.8%) |
| Sept 2022 | - | $8.96 B(-17.5%) |
| June 2022 | - | $10.86 B(+9.0%) |
| Mar 2022 | - | $9.96 B(+170.0%) |
| Dec 2021 | $33.92 B(-14.7%) | $3.69 B(-63.6%) |
| Sept 2021 | - | $10.13 B(+3.3%) |
| June 2021 | - | $9.81 B(-4.5%) |
| Mar 2021 | - | $10.28 B(-1.0%) |
| Dec 2020 | $39.75 B(+0.4%) | $10.39 B(+2.6%) |
| Sept 2020 | - | $10.13 B(+9.2%) |
| June 2020 | - | $9.27 B(-7.0%) |
| Mar 2020 | - | $9.96 B(-8.5%) |
| Dec 2019 | $39.59 B(+5.0%) | $10.89 B(+7.6%) |
| Sept 2019 | - | $10.12 B(+8.2%) |
| June 2019 | - | $9.36 B(+1.6%) |
| Mar 2019 | - | $9.21 B(-12.5%) |
| Dec 2018 | $37.70 B(+8.6%) | $10.54 B(+15.2%) |
| Sept 2018 | - | $9.15 B(-0.8%) |
| June 2018 | - | $9.22 B(+4.9%) |
| Mar 2018 | - | $8.79 B(+104.9%) |
| Dec 2017 | $34.70 B(-15.7%) | $4.29 B(-58.5%) |
| Sept 2017 | - | $10.34 B(+1.2%) |
| June 2017 | - | $10.21 B(+3.6%) |
| Mar 2017 | - | $9.86 B(-11.6%) |
| Dec 2016 | $41.17 B(-0.6%) | $11.15 B(+10.7%) |
| Sept 2016 | - | $10.07 B(-4.9%) |
| June 2016 | - | $10.59 B(+13.1%) |
| Mar 2016 | - | $9.36 B(-15.9%) |
| Dec 2015 | $41.41 B(-2.7%) | $11.13 B(+8.5%) |
| Sept 2015 | - | $10.25 B(-3.4%) |
| June 2015 | - | $10.62 B(+12.7%) |
| Mar 2015 | - | $9.42 B(-14.4%) |
| Dec 2014 | $42.55 B(+1.9%) | $11.00 B(+4.2%) |
| Sept 2014 | - | $10.56 B(-1.9%) |
| June 2014 | - | $10.77 B(+5.4%) |
| Mar 2014 | - | $10.22 B(-9.6%) |
| Dec 2013 | $41.73 B(+3.1%) | $11.29 B(+9.2%) |
| Sept 2013 | - | $10.35 B(+1.0%) |
| June 2013 | - | $10.25 B(-9.4%) |
| Mar 2013 | - | $11.31 B(+67.2%) |
| Dec 2012 | $40.46 B | $6.76 B(-39.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | $11.09 B(-3.0%) |
| June 2012 | - | $11.43 B(+2.3%) |
| Mar 2012 | - | $11.18 B(-19.6%) |
| Dec 2011 | $48.59 B(+21.4%) | $13.90 B(+15.0%) |
| Sept 2011 | - | $12.08 B(+2.4%) |
| June 2011 | - | $11.80 B(+9.1%) |
| Mar 2011 | - | $10.81 B(-9.9%) |
| Dec 2010 | $40.03 B(+14.0%) | $12.00 B(+17.2%) |
| Sept 2010 | - | $10.23 B(+14.2%) |
| June 2010 | - | $8.96 B(+1.3%) |
| Mar 2010 | - | $8.85 B(-15.8%) |
| Dec 2009 | $35.12 B(+4.5%) | $10.51 B(+21.4%) |
| Sept 2009 | - | $8.66 B(+3.3%) |
| June 2009 | - | $8.38 B(+7.4%) |
| Mar 2009 | - | $7.80 B(-10.0%) |
| Dec 2008 | $33.62 B(+4.5%) | $8.67 B(-0.3%) |
| Sept 2008 | - | $8.70 B(+1.9%) |
| June 2008 | - | $8.53 B(+10.4%) |
| Mar 2008 | - | $7.73 B(-21.7%) |
| Dec 2007 | $32.17 B(+17.1%) | $9.86 B(+26.9%) |
| Sept 2007 | - | $7.78 B(+5.7%) |
| June 2007 | - | $7.36 B(+4.5%) |
| Mar 2007 | - | $7.04 B(-11.2%) |
| Dec 2006 | $27.46 B(+18.1%) | $7.93 B(+12.5%) |
| Sept 2006 | - | $7.04 B(+9.3%) |
| June 2006 | - | $6.44 B(+5.8%) |
| Mar 2006 | - | $6.09 B(+24.6%) |
| Dec 2005 | $23.25 B(+9.9%) | $4.89 B(-25.9%) |
| Sept 2005 | - | $6.60 B(+9.6%) |
| June 2005 | - | $6.02 B(+6.4%) |
| Mar 2005 | - | $5.66 B(+3.0%) |
| Dec 2004 | $21.16 B(+9.7%) | $5.50 B(+2.9%) |
| Sept 2004 | - | $5.34 B(+3.1%) |
| June 2004 | - | $5.18 B(+0.7%) |
| Mar 2004 | - | $5.14 B(-5.5%) |
| Dec 2003 | $19.30 B(+22.2%) | $5.44 B(+14.8%) |
| Sept 2003 | - | $4.74 B(+0.0%) |
| June 2003 | - | $4.74 B(+8.5%) |
| Mar 2003 | - | $4.37 B(+4.4%) |
| Dec 2002 | $15.79 B(+9.3%) | $4.18 B(+9.6%) |
| Sept 2002 | - | $3.82 B(-8.2%) |
| June 2002 | - | $4.16 B(+24.4%) |
| Dec 2001 | $14.44 B(-16.6%) | - |
| June 2001 | - | $3.34 B(+1.9%) |
| Dec 2000 | $17.30 B(+9.7%) | - |
| June 2000 | - | $3.28 B |
| Dec 1999 | $15.78 B(-12.4%) | - |
| Dec 1998 | $18.01 B | - |
FAQ
- What is Novartis AG annual total expenses?
- What is the all time high annual total expenses for Novartis AG?
- What is Novartis AG annual total expenses year-on-year change?
- What is Novartis AG quarterly total expenses?
- What is the all time high quarterly total expenses for Novartis AG?
- What is Novartis AG quarterly total expenses year-on-year change?
What is Novartis AG annual total expenses?
The current annual total expenses of NVS is $36.89 B
What is the all time high annual total expenses for Novartis AG?
Novartis AG all-time high annual total expenses is $48.59 B
What is Novartis AG annual total expenses year-on-year change?
Over the past year, NVS annual total expenses has changed by +$1.38 B (+3.87%)
What is Novartis AG quarterly total expenses?
The current quarterly total expenses of NVS is $9.54 B
What is the all time high quarterly total expenses for Novartis AG?
Novartis AG all-time high quarterly total expenses is $13.90 B
What is Novartis AG quarterly total expenses year-on-year change?
Over the past year, NVS quarterly total expenses has changed by -$785.00 M (-7.60%)